Physician profile
Randi Jacobs
NPI 1063127967
$591.60
in general payments reported to CMS, 2019-2025
16 companies · $86.51 in 2025
The $86.51 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $478 · 2024: $27.38 · 2025: $86.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $298 · Education: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $297.66 |
| Education | $293.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $301.97 | 2023 | Veozah |
| Hologic Sales and Service, LLC | $38.75 | 2025 | Aptima, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Exeltis, USA INC. | $27.88 | 2024-2025 | Tyblume, Slynd |
| Takeda Pharmaceuticals U.S.A., INC. | $27.03 | 2023-2024 | Trintellix |
| Gilead Sciences, INC. | $21.46 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $20.13 | 2023 | Rexulti |
| Novo Nordisk INC | $17.67 | 2023 | Rybelsus, Ozempic |
| Mayne Pharma Commercial LLC | $17.54 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $16.62 | 2023 | Seglentis, Livalo |
| Sage Therapeutics, LLC | $16.40 | 2025 | Zurzuvae |
| Lilly USA, LLC | $15.72 | 2023 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.72 | 2023 | Xifaxan |
| La Jolla Pharmaceutical Company | $14.58 | 2023 | Xerava |
| Bayer Healthcare Pharmaceuticals INC. | $14.52 | 2023 | |
| Merck Sharp & Dohme LLC | $14.47 | 2023 | Vaxelis, Gardasil 9, Vaxneuvance |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $12.14 | 2023 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randi Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.